Novartis (Blood Transfusion Diagnostics Unit) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Novartis (Blood Transfusion Diagnostics Unit) General Information

Description

Provider of blood transfusion testing services. The company primarily focuses on increasing transfusion safety with nucleic acid testing, blood testing products and immunoassay reagents that detect infectious disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Emeryville, CA
  • United States
Primary Industry
Biotechnology
Acquirer
Grifols
Vertical(s)
Life Sciences
Corporate Office
  • Emeryville, CA
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novartis (Blood Transfusion Diagnostics Unit) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novartis (Blood Transfusion Diagnostics Unit)‘s full profile, request access.

Request a free trial

Novartis (Blood Transfusion Diagnostics Unit) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novartis (Blood Transfusion Diagnostics Unit)‘s full profile, request access.

Request a free trial

Novartis (Blood Transfusion Diagnostics Unit) FAQs

  • Where is Novartis (Blood Transfusion Diagnostics Unit) headquartered?

    Novartis (Blood Transfusion Diagnostics Unit) is headquartered in Emeryville, CA.

  • What industry is Novartis (Blood Transfusion Diagnostics Unit) in?

    Novartis (Blood Transfusion Diagnostics Unit)’s primary industry is Biotechnology.

  • Is Novartis (Blood Transfusion Diagnostics Unit) a private or public company?

    Novartis (Blood Transfusion Diagnostics Unit) is a Private company.

  • What is the current valuation of Novartis (Blood Transfusion Diagnostics Unit)?

    The current valuation of Novartis (Blood Transfusion Diagnostics Unit) is .

  • What is Novartis (Blood Transfusion Diagnostics Unit)’s current revenue?

    The current revenue for Novartis (Blood Transfusion Diagnostics Unit) is .

  • Who are Novartis (Blood Transfusion Diagnostics Unit)’s investors?

    Novartis has invested in Novartis (Blood Transfusion Diagnostics Unit).

  • When was Novartis (Blood Transfusion Diagnostics Unit) acquired?

    Novartis (Blood Transfusion Diagnostics Unit) was acquired on 09-Jan-2014.

  • Who acquired Novartis (Blood Transfusion Diagnostics Unit)?

    Novartis (Blood Transfusion Diagnostics Unit) was acquired by Grifols.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »